For patients with a dangerous enlargement of heart muscle called left ventricular hypertrophy (LVH), the drug Losartan beats standard beta-blocker therapy in reducing hearts to a healthier size, according to researchers at NewYork Presbyterian Hospital/Weill Cornell Medical Center.

Within minutes of a stroke or other brain injury, neurons begin to die, a process that is followed by a cascade of further cell death, due in part to proteins released from injured cells. These proteins tell surrounding, healthy cells to die, a process termed apoptosis. These events occur over several days and may be more devastating than the original injury.

The looming threat of bacterial infections resistant to available antibiotics can be averted if industry, regulators, and academics work together in creative new ways, writes Weill Cornell Medical College expert Dr. Carl Nathan in a commentary in the October 21 Nature.

The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital and the Morgan Stanley Children's Hospital of NewYork-Presbyterian in New York City today announced a joint venture to create a pediatric cardiac surgery program at the New Jersey hospital.

A breakthrough technology being developed by Dr. Scott C. Blanchard -- recently recruited to Weill Medical College of Cornell University under the College's Strategic Research Plan -- is finally allowing researchers an unprecedented view into the workings of individual molecules.

Current treatment thresholds for preventing osteoporosis-related bone fracture in postmenopausal women were evaluated in a study authored by a physician-scientist at NewYork-Presbyterian Hospital/Columbia University Medical Center and published in the May 24 issue of The Archives of Internal Medicine. The study found that a significant percentage of the 149,524 postmenopausal women enrolled in the National Osteoporosis Risk Assessment (NORA), experienced bone fractures despite having tested with a bone mineral density (BMD) outside of the risk parameters defined by the World Health Organization (WHO) and the National Osteoporosis Foundation (NOF).

With the help of NewYork-Presbyterian/Weill Cornell scientists, a couple now have a healthy baby boy, free of a disfiguring genetic ailment that has plagued the father and his family for generations.